Home ETF List About

Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIUHE.AS(EUR) CXE
ETF TickerIUHE(EUR) Euronext Amsterdam

Holdings detail for VTRS

Stock NameViatris Inc
TickerVTRS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92556V1061
LEI254900ZZTSW7NL773X71

Show aggregate VTRS holdings

News associated with VTRS

Notable ETF Inflow Detected - SPYD, CVS, VTRS, HPQ
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 High Dividend ETF (Symbol: SPYD) where we have detected an approximate $224.1 million dollar inflow -- that's a 3.1% incre - 2025-09-05 11:52:24
Look Under The Hood: EPS Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-27 08:41:51
Viatris: FDA Approves First Generic Iron Sucrose Injection
(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with chronic kidney disease. The FDA granted Viatris a competitive generic therapy d - 2025-08-11 10:43:53
Viatris Reports Positive Data From Presbyopia Study
(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects. - 2025-06-26 08:50:42
Do Wall Street Analysts Like Viatris Stock?
Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 12:38:15
Do Wall Street Analysts Like Viatris Stock?
Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 10:39:01
Do Wall Street Analysts Like Viatris Stock?
Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 08:37:13
What to Expect From Viatris' Q1 2025 Earnings Report
Viatris is scheduled to report its first-quarter results next month, and analysts expect a double-digit earnings drop. - 2025-04-28 10:58:09
Congress Trade: Representative Gilbert Ray Cisneros, Jr. Just Disclosed New Stock Trades
Representative Gilbert Ray Cisneros, Jr. just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Gilbert Ray Cisneros, Jr. and o - 2025-04-08 11:02:22
How Is Viatris’ Stock Performance Compared to Other Biotech Stocks?
Over the past six months, Viatris has lagged behind its biotech peers, and Wall Street analysts continue to exercise caution regarding the stock's future outlook. - 2025-04-01 09:11:05
Sum Up The Pieces: RPV Could Be Worth $108
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-20 08:35:50
Chip Stock Weakness and Tariff Angst Sink Stocks
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.45% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.75%. March E-mini S&P futures (ESH25 ) are down -1.56%, and March E-mini Nasdaq futures... - 2025-02-28 12:31:03
Nasdaq Slumps on Nvidia Weakness as Tariff Anxieties Loom Large
The S&P 500 Index ($SPX ) (SPY ) today is down -1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.35%. March E-mini S&P futures (ESH25 ) are down -1.34%, and March E-mini Nasdaq futures... - 2025-02-27 19:45:02
Stocks Trade Mixed as Chip Stocks Slide
The S&P 500 Index ($SPX ) (SPY ) today is down -0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.67%. March E-mini S&P futures (ESH25 ) are down -0.10%, and March E-mini Nasdaq futures... - 2025-02-27 18:41:22
Stocks Give Up Early Gains on Tariff Concerns
The S&P 500 Index ($SPX ) (SPY ) today is down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.79%. March E-mini S&P futures (ESH25 ) are down -0.44%, and March E-mini Nasdaq futures... - 2025-02-27 18:23:08
Daily Dividend Report: NVDA,ALL,RY,TD,VTRS
NVIDIA will pay its next quarterly cash dividend of $0.01 per share on April 2, 2025, to all shareholders of record on March 12, 2025. Allstate announced that its board of directors approved a quarterly common stock dividend of $1.00 on Feb. 26, 2025, which is an increase of $0 - 2025-02-27 15:01:58
Viatris Stock Outlook: Is Wall Street Bullish or Bearish?
As Viatris has trailed the broader market over the past year, analysts are skeptical about its future outlook. - 2025-02-05 10:35:40
After Hours Most Active for Jan 31, 2025 : NVDA, VTRS, GRAB, AAPL, VZ, HRL, WBD, DOC, IP, ES, GOOGL, KIM
The NASDAQ 100 After Hours Indicator is down -17.78 to 21,460.27. The total After hours volume is currently 176,419,368 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is +0.2393 at $120.31, with 11,968,760 shares tra - 2025-01-31 19:24:54
S&P 500 Movers: TXT, NFLX
In early trading on Wednesday, shares of Netflix topped the list of the day's best performing components of the S&P 500 index, trading up 12.9%. Year to date, Netflix registers a 10.2% gain. And the worst performing S&P 500 component thus far on the day is Textron, tra - 2025-01-22 13:19:25

iShares S&P 500 Health Care Sector UCITS ETF VTRS holdings

DateNumber of VTRS Shares HeldBase Market Value of VTRS SharesLocal Market Value of VTRS SharesChange in VTRS Shares HeldChange in VTRS Base ValueCurrent Price per VTRS Share HeldPrevious Price per VTRS Share Held
2025-09-29 (Monday)546,012USD 5,252,635USD 5,252,635
2025-09-26 (Friday)546,012USD 5,198,034USD 5,198,034
2025-09-25 (Thursday)546,012USD 5,181,654USD 5,181,654
2025-09-24 (Wednesday)546,012USD 5,301,777USD 5,301,777
2025-09-18 (Thursday)565,653VTRS holding increased by 668USD 5,577,339VTRS holding increased by 142183USD 5,577,339668USD 142,183 USD 9.86 USD 9.62
2025-09-17 (Wednesday)564,985USD 5,435,156VTRS holding increased by 33899USD 5,435,1560USD 33,899 USD 9.62 USD 9.56
2025-09-16 (Tuesday)564,985USD 5,401,257VTRS holding decreased by -22599USD 5,401,2570USD -22,599 USD 9.56 USD 9.6
2025-09-15 (Monday)564,985USD 5,423,856USD 5,423,856
2025-09-12 (Friday)564,985USD 5,627,251USD 5,627,251
2025-09-11 (Thursday)563,245USD 5,728,202USD 5,728,202
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VTRS by Blackrock for IE00BMBKBZ46

Show aggregate share trades of VTRS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY668 9.860* 9.91
2025-08-20BUY1,320 10.650* 9.90
2025-08-19BUY661 10.680* 9.90
2025-08-18BUY3,305 10.630* 9.89
2025-08-15BUY9,944 10.610* 9.89
2025-08-14BUY4,008 10.690* 9.89
2025-08-13BUY2,672 10.410* 9.88
2025-07-30BUY667 9.000* 9.89
2025-07-17SELL-667 9.270* 9.93 Profit of 6,620 on sale
2025-07-15SELL-2,668 8.930* 9.94 Profit of 26,512 on sale
2025-07-14SELL-6,670 9.140* 9.94 Profit of 66,315 on sale
2025-07-09SELL-667 9.230* 9.96 Profit of 6,641 on sale
2025-07-07SELL-1,334 9.200* 9.97 Profit of 13,296 on sale
2025-07-02BUY667 9.340* 9.98
2025-06-24SELL-11,373 8.950* 10.02 Profit of 113,906 on sale
2025-06-23BUY669 8.850* 10.02
2025-06-20SELL-1,338 8.870* 10.03 Profit of 13,423 on sale
2025-06-18SELL-669 8.770* 10.05 Profit of 6,724 on sale
2025-06-17BUY8,016 8.760* 10.06
2025-06-13SELL-1,336 8.920* 10.08 Profit of 13,462 on sale
2025-06-11SELL-668 8.980* 10.09 Profit of 6,742 on sale
2025-06-10SELL-1,336 9.040* 10.10 Profit of 13,494 on sale
2025-06-09SELL-2,004 8.810* 10.11 Profit of 20,261 on sale
2025-05-21SELL-668 8.480* 10.28 Profit of 6,867 on sale
2025-05-20SELL-1,336 8.880* 10.29 Profit of 13,751 on sale
2025-05-15SELL-2,004 8.790* 10.33 Profit of 20,706 on sale
2025-05-14SELL-2,004 8.420* 10.35 Profit of 20,740 on sale
2025-05-13BUY668 8.790* 10.36
2025-05-09SELL-668 8.770* 10.39 Profit of 6,941 on sale
2025-05-08BUY1,336 9.090* 10.40
2025-05-01BUY1,336 8.470* 10.49
2025-04-24SELL-668 8.030* 10.61 Profit of 7,086 on sale
2025-04-23BUY2,004 7.810* 10.64
2025-04-15SELL-669 7.480* 10.84 Profit of 7,252 on sale
2025-04-10SELL-1,292 7.260* 10.96 Profit of 14,154 on sale
2025-04-08SELL-646 7.360* 11.03 Profit of 7,128 on sale
2025-04-07SELL-646 7.610* 11.07 Profit of 7,154 on sale
2025-04-04SELL-1,292 7.620* 11.12 Profit of 14,361 on sale
2025-04-02BUY645 8.660* 11.14
2025-04-01BUY5,796 8.600* 11.18
2025-03-31SELL-3,876 8.710* 11.21 Profit of 43,435 on sale
2025-03-28BUY645 8.680* 11.24
2025-03-26SELL-437 8.960* 11.30 Profit of 4,937 on sale
2025-03-21BUY4,508 9.150* 11.38
2025-03-20BUY2,652 9.440* 11.41
2025-03-17SELL-663 9.250* 11.50 Profit of 7,622 on sale
2025-03-12BUY17,658 9.240* 11.60
2025-03-07BUY645 9.650* 11.70
2025-02-28SELL-1,935 9.230* 11.85 Profit of 22,934 on sale
2025-02-25BUY6,450 11.480* 11.91
2025-02-20BUY4,515 11.060* 11.95
2025-02-19BUY1,935 10.930* 11.96
2025-02-18BUY1,290 10.860* 11.99
2025-02-13BUY3,225 10.800* 12.06
2025-02-04BUY2,580 10.890* 12.27
2025-01-31BUY645 11.280* 12.32
2025-01-29BUY645 11.330* 12.37
2025-01-27BUY1,290 11.420* 12.43
2025-01-24BUY645 11.200* 12.46
2025-01-02SELL-23,166 12.420* 12.50 Profit of 289,630 on sale
2024-12-10SELL-637 12.510* 12.50 Profit of 7,964 on sale
2024-12-09SELL-16,562 12.800* 12.49 Profit of 206,906 on sale
2024-12-03SELL-7,536 13.000* 12.43 Profit of 93,694 on sale
2024-12-02SELL-3,135 13.200* 12.40 Profit of 38,888 on sale
2024-11-29SELL-643 13.090* 12.38 Profit of 7,959 on sale
2024-11-22SELL-6,360 13.370* 12.17 Profit of 77,404 on sale
2024-11-21SELL-3,180 13.250* 12.12 Profit of 38,530 on sale
2024-11-20BUY5,088 13.130* 12.06
2024-11-18SELL-7,547 13.000* 11.95 Profit of 90,187 on sale
2024-11-11BUY5,652 13.090* 11.81
2024-11-08SELL-20,032 12.960* 11.73 Profit of 234,904 on sale
2024-11-07SELL-1,244 13.180* 11.61 Profit of 14,449 on sale
2024-11-01SELL-1,244 11.620* 11.63 Profit of 14,472 on sale
2024-10-31SELL-2,556 11.600* 11.64 Profit of 29,745 on sale
2024-10-30BUY638 11.890* 11.60
2024-10-29BUY3,828 11.740* 11.58
2024-10-28SELL-1,914 11.760* 11.54 Profit of 22,091 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VTRS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-193,353,35406,659,56650.4%
2025-09-182,699,7755,3004,638,73158.2%
2025-09-171,294,10303,239,90239.9%
2025-09-161,697,0942,1893,878,50043.8%
2025-09-153,294,1104,6536,232,68452.9%
2025-09-122,119,5691055,453,58938.9%
2025-09-112,172,2202,2575,247,56341.4%
2025-09-101,225,76142,655,03846.2%
2025-09-091,269,87262,506,79250.7%
2025-09-081,481,7707,2973,027,36948.9%
2025-09-051,173,3582922,484,65847.2%
2025-09-041,214,0639,8112,826,83542.9%
2025-09-031,354,9514,6702,373,28457.1%
2025-09-021,331,3932,7682,534,61152.5%
2025-08-291,981,38016,9784,227,52846.9%
2025-08-281,431,4104812,945,86848.6%
2025-08-271,135,9633,1172,853,80739.8%
2025-08-261,694,6568,2023,382,02150.1%
2025-08-251,167,6755,1892,730,44642.8%
2025-08-22938,1299082,610,63635.9%
2025-08-211,484,26503,449,91243.0%
2025-08-201,377,7573162,609,96652.8%
2025-08-192,079,19310,6993,438,37760.5%
2025-08-181,595,8739,6113,130,66151.0%
2025-08-151,789,7081302,639,81067.8%
2025-08-142,291,9482,2404,236,26454.1%
2025-08-131,855,3293,2292,958,45962.7%
2025-08-122,928,34214,9265,321,62855.0%
2025-08-114,225,64822,5697,215,51858.6%
2025-08-083,302,1711219,100,68036.3%
2025-08-071,866,3966,1325,539,13733.7%
2025-08-061,436,9006,5334,016,55035.8%
2025-08-05915,574482,865,82331.9%
2025-08-04970,52502,561,10937.9%
2025-08-011,004,9625,7512,847,53135.3%
2025-07-311,315,1746003,289,88740.0%
2025-07-30593,2404,0451,887,60731.4%
2025-07-29876,9362,6172,154,79540.7%
2025-07-28835,6461,9002,106,37739.7%
2025-07-25871,3805991,939,23944.9%
2025-07-24575,023521,884,04430.5%
2025-07-23823,3561422,063,47539.9%
2025-07-222,314,7412,7955,125,60245.2%
2025-07-21888,3872,4612,393,90337.1%
2025-07-181,905,8131,2103,830,56549.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.